References
1. Parsonnet, V., D. Dean, and A.D.
Bernstein, A method of uniform stratification of risk for
evaluating the results of surgery in acquired adult heart disease.Circulation, 1989. 79 (6 Pt 2): p. I3-12.
2. Granton, J. and D. Cheng,Risk stratification models for cardiac surgery. Semin
Cardiothorac Vasc Anesth, 2008. 12 (3): p. 167-74.
3. Rosenhek, R., et al., ESC
Working Group on Valvular Heart Disease Position Paper: assessing the
risk of interventions in patients with valvular heart disease. Eur
Heart J, 2012. 33 (7): p. 822-8, 828a, 828b.
4. Ad, N., et al., Comparison of
EuroSCORE II, Original EuroSCORE, and The Society of Thoracic Surgeons
Risk Score in Cardiac Surgery Patients. Ann Thorac Surg, 2016.102 (2): p. 573-9.
5. Prins, C., et al., Cardiac
surgery risk-stratification models. Cardiovasc J Afr, 2012.23 (3): p. 160-4.
6. AlJaroudi, W.A., et al.,Prognostic value of diastolic dysfunction: state of the art
review. Cardiol Rev, 2014. 22 (2): p. 79-90.
7. Swaminathan, M., et al.,Utility of a simple algorithm to grade diastolic dysfunction and
predict outcome after coronary artery bypass graft surgery. Ann Thorac
Surg, 2011. 91 (6): p. 1844-50.
8. Metkus, T.S., et al.,Diastolic dysfunction is common and predicts outcome after cardiac
surgery. J Cardiothorac Surg, 2018. 13 (1): p. 67.
9. Singh, H., et al., Comparison
of left atrial dimensions by transesophageal and transthoracic
echocardiography. Echocardiography, 2005. 22 (10): p. 789-96.
10. Eshoo, S., D.L. Ross, and L.
Thomas, Evaluation of left atrial size on transoesophageal
echocardiography: what is the best measure? Heart Lung Circ, 2008.17 (2): p. 100-6.
11. Ancona, R., et al., Left
atrium by echocardiography in clinical practice: from conventional
methods to new echocardiographic techniques. ScientificWorldJournal,
2014. 2014 : p. 451042.
12. Cameli, M., et al., Novel
echocardiographic techniques to assess left atrial size, anatomy and
function. Cardiovasc Ultrasound, 2012. 10 : p. 4.
13. Mor-Avi, V., et al.,Real-time 3D echocardiographic quantification of left atrial
volume: multicenter study for validation with CMR. JACC Cardiovasc
Imaging, 2012. 5 (8): p. 769-77.
14. Swaminathan, M., et al.,Utility of a simple algorithm to grade diastolic dysfunction and
predict outcome after coronary artery bypass graft surgery. Ann Thorac
Surg, 2011. 91 (6): p. 1844-50.
15. Nagueh, S.F., et al.,Recommendations for the Evaluation of Left Ventricular Diastolic
Function by Echocardiography: An Update from the American Society of
Echocardiography and the European Association of Cardiovascular
Imaging. J Am Soc Echocardiogr, 2016. 29 (4): p. 277-314.
16. Roy, A.K., et al., A
Comparison of Traditional and Novel Definitions (RIFLE, AKIN, and KDIGO)
of Acute Kidney Injury for the Prediction of Outcomes in Acute
Decompensated Heart Failure. Cardiorenal Med, 2013. 3 (1): p.
26-37.
17. Muthen, B. and L.K. Muthen,Integrating person-centered and variable-centered analyses: growth
mixture modeling with latent trajectory classes. Alcohol Clin Exp Res,
2000. 24 (6): p. 882-91.
18. Wolters, U., et al., ASA
classification and perioperative variables as predictors of
postoperative outcome. Br J Anaesth, 1996. 77 (2): p. 217-22.
19. Hackett, N.J., et al., ASA
class is a reliable independent predictor of medical complications and
mortality following surgery. Int J Surg, 2015. 18 : p. 184-90.
20. Somani, S., et al., ASA
Classification as a Risk Stratification Tool in Adult Spinal Deformity
Surgery: A Study of 5805 Patients. Global Spine J, 2017. 7 (8):
p. 719-726.
21. Merello, L., et al., Risk
scores do not predict high mortality after coronary artery bypass
surgery in the presence of diastolic dysfunction. Ann Thorac Surg,
2008. 85 (4): p. 1247-55.
22. Yusuf, S., et al., Effects
of candesartan in patients with chronic heart failure and preserved
left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet,
2003. 362 (9386): p. 777-81.
23. Cleland, J.G., et al., The
perindopril in elderly people with chronic heart failure (PEP-CHF)
study. Eur Heart J, 2006. 27 (19): p. 2338-45.
24. Massie, B.M., et al.,Irbesartan in patients with heart failure and preserved ejection
fraction. N Engl J Med, 2008. 359 (23): p. 2456-67.
25. Pitt, B., et al.,Spironolactone for heart failure with preserved ejection
fraction. N Engl J Med, 2014. 370 (15): p. 1383-92.
26. Redfield, M.M., et al.,Effect of phosphodiesterase-5 inhibition on exercise capacity and
clinical status in heart failure with preserved ejection fraction: a
randomized clinical trial. JAMA, 2013. 309 (12): p. 1268-77.
27. Okada, D.R., et al.,Clinical echocardiographic indices of left ventricular diastolic
function correlate poorly with pulmonary capillary wedge pressure at 1
year following heart transplantation. Int J Cardiovasc Imaging, 2015.31 (4): p. 783-94.
28. Ommen, S.R., et al.,Clinical utility of Doppler echocardiography and tissue Doppler
imaging in the estimation of left ventricular filling pressures: A
comparative simultaneous Doppler-catheterization study. Circulation,
2000. 102 (15): p. 1788-94.
29. Sharifov, O.F., et al.,Diagnostic Accuracy of Tissue Doppler Index E/e’ for Evaluating
Left Ventricular Filling Pressure and Diastolic Dysfunction/Heart
Failure With Preserved Ejection Fraction: A Systematic Review and
Meta-Analysis. J Am Heart Assoc, 2016. 5 (1).
30. Nagueh, S.F., et al.,Doppler tissue imaging: a noninvasive technique for evaluation of
left ventricular relaxation and estimation of filling pressures. J Am
Coll Cardiol, 1997. 30 (6): p. 1527-33.